NFA
SRPT icon

Nationwide Fund Advisors’s Sarepta Therapeutics SRPT Stock Holding History

Nationwide Fund Advisors’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-32,906
Closed -$1.49M – 1809
2017
Q3 		$1.49M Buy
32,906
+3,440
+12% +$137K 0.01% 1584
2017
Q2 		$993K Sell
29,466
-80
-0.3% -$2.6K ﹤0.01% 1782
2017
Q1 		$875K Sell
29,546
-10,625
-26% -$329K ﹤0.01% 1841
2016
Q4 		$1.1M Buy
40,171
+4,004
+11% +$161K ﹤0.01% 1713
2016
Q3 		$2.22M Buy
36,167
+8,120
+29% +$245K 0.01% 1339
2016
Q2 		$535K Sell
28,047
-677
-2% -$12.5K ﹤0.01% 2123
2016
Q1 		$575K Sell
28,724
-499
-2% -$8.72K ﹤0.01% 2021
2015
Q4 		$1.13M Buy
29,223
+2,471
+9% +$80.1K ﹤0.01% 1671
2015
Q3 		$859K Sell
26,752
-125
-0.5% -$4.24K ﹤0.01% 1809
2015
Q2 		$818K Sell
26,877
-3,008
-10% -$61.5K ﹤0.01% 1980
2015
Q1 		$397K Sell
29,885
-1,207
-4% -$16.1K ﹤0.01% 2356
2014
Q4 		$450K Sell
31,092
-373
-1% -$6.32K ﹤0.01% 2239
2014
Q3 		$664K Buy
31,465
+154
+0.5% +$3.48K ﹤0.01% 2048
2014
Q2 		$933K Buy
31,311
+2,212
+8% +$69.9K ﹤0.01% 1901
2014
Q1 		$699K Buy
29,099
+60
+0.2% +$1.53K ﹤0.01% 1903
2013
Q4 		$592K Buy
29,039
+2,359
+9% +$70.1K ﹤0.01% 2168
2013
Q3 		$1.26M Buy
26,680
+16,420
+160% +$632K 0.01% 1723
2013
Q2 		$390K Buy
+10,260
New +$367K ﹤0.01% 2133

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Nationwide Fund Advisors's SRPT Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Sarepta Therapeutics (SRPT) in Q4 2017, closing a stake of 32,906 shares — an estimated $1.49M sold.

Nationwide Fund Advisors first reported a position in SRPT in Q2 2013 and held it in 18 quarters. The position peaked at $2.22M in Q3 2016. 254 funds tracked by Wall St. Rank hold SRPT as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Sarepta Therapeutics position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 32,906 Sarepta Therapeutics shares in Q4 2017, an estimated $1.49M.
  • Nationwide Fund Advisors first reported a position in Sarepta Therapeutics in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Sarepta Therapeutics position peaked at $2.22M in Q3 2016.
  • 254 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.